Patents by Inventor James Griesser

James Griesser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL
    Publication number: 20240189255
    Abstract: A pharmaceutical composition, and methods for using a pharmaceutical composition, for treating osteoarthritis in a subject in need thereof, the pharmaceutical composition including cannabidiol or a pharmaceutically acceptable salt thereof; and especially wherein administration of the cannabidiol is by a transdermal pharmaceutical gel composition. A method is disclosed for treating one or more symptoms of osteoarthritis in a patient. The method includes transdermally administering an effective amount of cannabidiol (CBD) to the patient wherein one or more symptoms of osteoarthritis are treated in the patient.
    Type: Application
    Filed: June 13, 2023
    Publication date: June 13, 2024
    Applicant: ZYNERBA PHARMACEUTICALS, INC.
    Inventors: Nancy Tich, John Messenheimer, Donna Gutterman, Daniel Clauw, Ted Smith, James Griesser
  • METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL
    Publication number: 20240148669
    Abstract: A pharmaceutical composition, and methods for using a pharmaceutical composition, for treating osteoarthritis in a subject in need thereof, the pharmaceutical composition including cannabidiol or a pharmaceutically acceptable salt thereof; and especially wherein administration of the cannabidiol is by a transdermal pharmaceutical gel composition. A method is disclosed for treating one or more symptoms of osteoarthritis in a patient. The method includes transdermally administering an effective amount of cannabidiol (CBD) to the patient wherein one or more symptoms of osteoarthritis are treated in the patient.
    Type: Application
    Filed: October 6, 2023
    Publication date: May 9, 2024
    Applicant: ZYNERBA PHARMACEUTICALS, INC.
    Inventors: Nancy Tich, John Messenheimer, Donna Gutterman, Daniel Clauw, Ted Smith, James Griesser
  • TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
    Publication number: 20240122873
    Abstract: The present technology relates to a method of treating one or more symptoms of Full Methylation (Fmet) Fragile X Syndrome in a subject that includes administering an effective amount of cannabidiol to the subject such that one or more symptoms of Fragile X Syndrome are treated.
    Type: Application
    Filed: October 9, 2023
    Publication date: April 18, 2024
    Applicant: ZYNERBA PHARMACEUTICALS, INC.
    Inventors: James Griesser, Thomas W. Dobbins, Terri Sebree
  • TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
    Publication number: 20210401769
    Abstract: The present technology relates to a method of treating one or more symptoms of Full Methylation (Fmet) Fragile X Syndrome in a subject that includes administering an effective amount of cannabidiol to the subject such that one or more symptoms of Fragile X Syndrome are treated.
    Type: Application
    Filed: June 28, 2021
    Publication date: December 30, 2021
    Applicant: ZYNERBA PHARMACEUTICALS, INC.
    Inventors: James Griesser, Thomas W. Dobbins, Terri Sebree